Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Short-Term Debt issuances (2018 - 2022)

Phibro Animal Health has reported Short-Term Debt issuances over the past 5 years, most recently at -$1.9 million for Q1 2022.

  • Quarterly results put Short-Term Debt issuances at -$1.9 million for Q1 2022, up 60.0% from a year ago — trailing twelve months through Mar 2022 was -$212.2 million (down 1132.0% YoY), and the annual figure for FY2021 was -$220.6 million, down 1644.62%.
  • Short-Term Debt issuances for Q1 2022 was -$1.9 million at Phibro Animal Health, roughly flat from -$1.9 million in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for PAHC hit a ceiling of -$1.9 million in Q3 2021 and a floor of -$206.6 million in Q2 2021.
  • Median Short-Term Debt issuances over the past 5 years was -$3.1 million (2019), compared with a mean of -$16.8 million.
  • Peak annual rise in Short-Term Debt issuances hit 60.0% in 2021, while the deepest fall reached 6436.77% in 2021.
  • Phibro Animal Health's Short-Term Debt issuances stood at -$3.1 million in 2018, then decreased by 0.06% to -$3.1 million in 2019, then tumbled by 48.98% to -$4.7 million in 2020, then skyrocketed by 60.0% to -$1.9 million in 2021, then changed by 0.0% to -$1.9 million in 2022.
  • The last three reported values for Short-Term Debt issuances were -$1.9 million (Q1 2022), -$1.9 million (Q4 2021), and -$1.9 million (Q3 2021) per Business Quant data.